For a few hours on Wednesday, the sleepy airport of El Paso, Texas, became a sudden flashpoint for confusion. Late Tuesday night, the Federal Aviation Administration issued a terse notice to pilots that airspace in the area would close - for an unprecedented 10 days - due to “special security reasons”. And then almost as suddenly, the FAA lifted the restrictions on Wednesday morning. Conflicting a...
For a few hours on Wednesday, the sleepy airport of El Paso, Texas, became a sudden flashpoint for confusion. Late Tuesday night, the Federal Aviation Administration issued a terse notice to pilots that airspace in the area would close - for an unprecedented 10 days - due to “special security reasons”. And then almost as suddenly, the FAA lifted the restrictions on Wednesday morning. Conflicting accounts of what prompted the action in the first place quickly emerged. Advertisement Trump administration officials including Transportation Secretary Sean Duffy said the shutdown was in response to drones operated by Mexican drug cartels that had breached US airspace. Duffy said in a social media post that the FAA and Defence Department “acted swiftly” to address the incursion, and had “neutralised” the threat. A satellite image of El Paso International Airport. Photo: Planet Labs PBC via Reuters Others with knowledge of the situation paint a different picture, one that suggests a communication breakdown between key parts of the US government.
These stocks have roared higher but still have room to run. If you're looking for growth in 2026 and beyond, it's a fantastic idea to add a few technology stocks to your portfolio. These players are leading innovation in many areas, and therefore, they're well-positioned to advance over the long term. You could choose stocks that have stumbled, offering you a bargain price, or you might select sto...
These stocks have roared higher but still have room to run. If you're looking for growth in 2026 and beyond, it's a fantastic idea to add a few technology stocks to your portfolio. These players are leading innovation in many areas, and therefore, they're well-positioned to advance over the long term. You could choose stocks that have stumbled, offering you a bargain price, or you might select stocks that are roaring higher, offering you incredible momentum. It's a great idea to use both strategies, picking up a few deals and adding a couple of high-powered performers to your portfolio. Here, I'll suggest two unstoppable players, companies that are ideally placed to benefit from the artificial intelligence (AI) boom. 1. Nvidia Nvidia (NVDA +0.86%) may seem like an obvious choice, and that's the reason why it's important to point out this stock. Some investors may see it as "yesterday's AI stock" and aim to look elsewhere for a future winner. While there surely are many young AI companies to discover, Nvidia remains a pillar of the industry -- and has plenty of room for additional gains even after the stock's increase of more than 1,100% over the past five years. Expand NASDAQ : NVDA Nvidia Today's Change ( 0.86 %) $ 1.63 Current Price $ 190.17 Key Data Points Market Cap $4.6T Day's Range $ 188.78 - $ 193.26 52wk Range $ 86.62 - $ 212.19 Volume 4.6M Avg Vol 181M Gross Margin 70.05 % Dividend Yield 0.02 % As cloud service providers and others invest in AI infrastructure, Nvidia, the world's leading AI chip designer, is likely to see increasing demand. Nvidia last year predicted AI infrastructure spending would reach into the trillions by the end of the decade. And the company continues to speak of high demand for its chips and related products. So right now is a fantastic time to own Nvidia shares. 2. Nebius Nebius (NBIS 3.14%) is another company that may benefit from AI needs now and in the years to come. It offers something that's in great demand: capacity for AI wo...
Key Points These tech stocks sell products and services that are key to the artificial intelligence boom. High demand has driven revenue growth at both companies. 10 stocks we like better than Nvidia › If you're looking for growth in 2026 and beyond, it's a fantastic idea to add a few technology stocks to your portfolio. These players are leading innovation in many areas, and therefore, they're we...
Key Points These tech stocks sell products and services that are key to the artificial intelligence boom. High demand has driven revenue growth at both companies. 10 stocks we like better than Nvidia › If you're looking for growth in 2026 and beyond, it's a fantastic idea to add a few technology stocks to your portfolio. These players are leading innovation in many areas, and therefore, they're well-positioned to advance over the long term. You could choose stocks that have stumbled, offering you a bargain price, or you might select stocks that are roaring higher, offering you incredible momentum. It's a great idea to use both strategies, picking up a few deals and adding a couple of high-powered performers to your portfolio. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Here, I'll suggest two unstoppable players, companies that are ideally placed to benefit from the artificial intelligence (AI) boom. 1. Nvidia Nvidia (NASDAQ: NVDA) may seem like an obvious choice, and that's the reason why it's important to point out this stock. Some investors may see it as "yesterday's AI stock" and aim to look elsewhere for a future winner. While there surely are many young AI companies to discover, Nvidia remains a pillar of the industry -- and has plenty of room for additional gains even after the stock's increase of more than 1,100% over the past five years. As cloud service providers and others invest in AI infrastructure, Nvidia, the world's leading AI chip designer, is likely to see increasing demand. Nvidia last year predicted AI infrastructure spending would reach into the trillions by the end of the decade. And the company continues to speak of high demand for its chips and related products. So right now is a fantastic time to own Nvidia shares. 2. Nebius Nebius (NASDAQ: NBIS) is another company that...
Investor concerns surrounding OpenAI and ChatGPT have caused this blue chip tech giant to slide. Artificial intelligence (AI) is the hottest growth story in the stock market by a mile. As a result, it hasn't been easy to find AI stocks in the bargain bin. However, Microsoft (MSFT 2.10%) has taken it on the chin lately. The stock now sits more than 20% off its high, its sharpest decline in several ...
Investor concerns surrounding OpenAI and ChatGPT have caused this blue chip tech giant to slide. Artificial intelligence (AI) is the hottest growth story in the stock market by a mile. As a result, it hasn't been easy to find AI stocks in the bargain bin. However, Microsoft (MSFT 2.10%) has taken it on the chin lately. The stock now sits more than 20% off its high, its sharpest decline in several years. What gives? Investors have raised concerns over OpenAI, in which Microsoft owns a 27% stake and partners closely. The situation has weighed so heavily on Microsoft stock that it may be time to swoop in and buy this dip. Here is why the tech giant is the best AI stock you can buy right now. Should investors worry about OpenAI? The company is burning through billions of dollars, which means it depends on continuously raising funds from investors to stay in business. Additionally, competitors such as Anthropic and Alphabet have eaten into OpenAI's market share. That's not a good combination. From Microsoft's perspective, the company depends heavily on OpenAI. Management disclosed during its fourth-quarter earnings that OpenAI accounts for roughly 45% of Azure's (cloud business) order backlog. In other words, if OpenAI fails, Microsoft's cloud business would implode. But OpenAI isn't throwing up its arms. The company is in talks to raise $100 billion to fund its near-term needs. ChatGPT is still the leading AI app. OpenAI is also releasing new products, including Frontier for enterprises, which allows companies to develop, deploy, and manage AI agents that can autonomously perform various tasks. OpenAI has become a risk to monitor, but it's far too early to panic. The company is just starting to open the door to some potentially massive revenue opportunities. Why Microsoft's decline is a strong buying opportunity If you look past OpenAI's drama, Microsoft just put up a pretty strong quarter. Its cloud business grew by 26% year over year to $51.5 billion, an impressive fe...
格隆汇2月12日｜高盛表示，在MSCI 2月份的指数调整后，中国股市有望迎来约14亿美元的被动资金流入。"从净值来看，亚太地区（中国14亿美元、澳大利亚2.7亿美元和新加坡1.6亿美元）预计将迎来最大的被动资金流入。" 高盛分析师Alvin So 周四在一份报告中写道。与此同时，韩国、印尼和泰国的资金外流规模预计将分别为2亿美元、1.2亿美元和6,500万美元。MSCI指数调整将于2月27日美股收...
格隆汇2月12日｜高盛表示，在MSCI 2月份的指数调整后，中国股市有望迎来约14亿美元的被动资金流入。"从净值来看，亚太地区（中国14亿美元、澳大利亚2.7亿美元和新加坡1.6亿美元）预计将迎来最大的被动资金流入。" 高盛分析师Alvin So 周四在一份报告中写道。与此同时，韩国、印尼和泰国的资金外流规模预计将分别为2亿美元、1.2亿美元和6,500万美元。MSCI指数调整将于2月27日美股收盘后生效。
These three dividend stocks are worth a close look for their solid business quality and attractive payouts. In a market where income investors have options, the 10-year Treasury yield of 4.2% serves as a "risk-free" rate. It represents the guaranteed return on government debt where principal loss is virtually non-existent. To compete with the relatively high rate, a dividend stock must offer price...
These three dividend stocks are worth a close look for their solid business quality and attractive payouts. In a market where income investors have options, the 10-year Treasury yield of 4.2% serves as a "risk-free" rate. It represents the guaranteed return on government debt where principal loss is virtually non-existent. To compete with the relatively high rate, a dividend stock must offer price appreciation and growth potential backed by solid coverage ratios. These three companies fit that bill. Trading members for pricing discipline UnitedHealth Group (UNH +2.03%) operates the nation's largest private health insurer, alongside Optum, a health services platform that provides pharmacy benefits, data analytics, and direct patient care. In an effort to support profitability, the company expects to lose up to 2.8 million members after increasing rates in response to rising medical costs. Shares recently dropped 20% following the release of fourth-quarter (Q4) results due in part to a rising medical care ratio (MCR) that reached 91.5%, its highest level since costs spiked last year. Making matters worse for the insurer, a proposed 0.09% increase for 2027 Medicare Advantage rates, well below industry expectations, arrived before the earnings release. Adding to the uncertainty is the ongoing Department of Justice (DOJ) criminal investigation into Medicare billing practices. Despite the ongoing uncertainty, the 3.2% dividend is safe. The business generated $16 billion in free cash flow (FCF) last year, funding the payout nearly twice over, and management expects earnings per share (EPS) growth of around 8.5% this year. After its recent retreat, the stock trades for 15.5 times next year's earnings target of $17.75 per share. A Nashville icon hiding in plain sight Ryman Hospitality Properties (RHP +0.57%) is a real estate investment trust (REIT) that owns large-scale convention resorts and iconic country music venues. Its portfolio features five of the seven largest non-g...
Teladoc Health saw a serious boom during the COVID-19 pandemic, but with stagnant and declining revenue and a lack of profitability, this company looks like it might end up as a relic of a brief but bygone era. Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. An...
Teladoc Health saw a serious boom during the COVID-19 pandemic, but with stagnant and declining revenue and a lack of profitability, this company looks like it might end up as a relic of a brief but bygone era. Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. And Teladoc Health's (TDOC 3.81%) share price is proof of that. There were a handful of companies back in 2020 that had incredible bull runs as the pandemic confined many to their homes. Teladoc was one of them. Teladoc, which offers a specialized place for doctors and patients to hold remote appointments, was founded back in 2002 and had its initial public offering (IPO) in 2015. And it had pretty steady share price growth from 2015 to 2020. Then, during the pandemic, Teladoc, Zoom, and other video-call programs saw explosive growth. When China first reported COVID-19 cases breaking out across the country in late 2019, Teladoc was trading for about $81 per share. Over the course of the next year the stock surged 224% and hit $263 per share in late January 2021. But then came the vaccine, and a slackening of pandemic-era restrictions, and by the end of 2023 life had mostly returned to normal. Unfortunately for Teladoc, so had its share price. The company finished 2023 at $21 per share, lower than it was pre-pandemic and a 92% decrease from its peak. Today it only trades for about $5, and even at these prices I wouldn't give Teladoc a look. It's fundamentally weak and lacks a real moat to protect itself. Expand NYSE : TDOC Teladoc Health Today's Change ( -3.81 %) $ -0.18 Current Price $ 4.67 Key Data Points Market Cap $861M Day's Range $ 4.54 - $ 4.83 52wk Range $ 4.54 - $ 15.21 Volume 235K Avg Vol 5.8M Gross Margin 55.61 % Somebody call a doctor Teladoc has one glaring problem shared by most of the video calling companies like it. There's a lot of competition, and it's easy t...
Key Points Ryman Hospitality offers investors a unique opportunity to earn income while investing in Music City. ONEOK’s diversified midstream scale supports strong cash-flow growth. UnitedHealth shares are at multiyear lows as it chooses margins over member count. 10 stocks we like better than UnitedHealth Group › In a market where income investors have options, the 10-year Treasury yield of 4.2%...
Key Points Ryman Hospitality offers investors a unique opportunity to earn income while investing in Music City. ONEOK’s diversified midstream scale supports strong cash-flow growth. UnitedHealth shares are at multiyear lows as it chooses margins over member count. 10 stocks we like better than UnitedHealth Group › In a market where income investors have options, the 10-year Treasury yield of 4.2% serves as a "risk-free" rate. It represents the guaranteed return on government debt where principal loss is virtually non-existent. To compete with the relatively high rate, a dividend stock must offer price appreciation and growth potential backed by solid coverage ratios. These three companies fit that bill. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Trading members for pricing discipline UnitedHealth Group (NYSE: UNH) operates the nation's largest private health insurer, alongside Optum, a health services platform that provides pharmacy benefits, data analytics, and direct patient care. In an effort to support profitability, the company expects to lose up to 2.8 million members after increasing rates in response to rising medical costs. Shares recently dropped 20% following the release of fourth-quarter (Q4) results due in part to a rising medical care ratio (MCR) that reached 91.5%, its highest level since costs spiked last year. Making matters worse for the insurer, a proposed 0.09% increase for 2027 Medicare Advantage rates, well below industry expectations, arrived before the earnings release. Adding to the uncertainty is the ongoing Department of Justice (DOJ) criminal investigation into Medicare billing practices. Despite the ongoing uncertainty, the 3.2% dividend is safe. The business generated $16 billion in free cash flow (FCF) last year, funding the payout nearly twice over, and management expects earnings per share (EPS) growth of ar...
Key Points Teladoc has seen its share price tumble 98% from its 2021 peak. It has declining revenue and is not profitable. The company has lots of competition and lacks a moat to protect itself or meaningfully set itself apart from the competition. 10 stocks we like better than Teladoc Health › Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pan...
Key Points Teladoc has seen its share price tumble 98% from its 2021 peak. It has declining revenue and is not profitable. The company has lots of competition and lacks a moat to protect itself or meaningfully set itself apart from the competition. 10 stocks we like better than Teladoc Health › Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. And Teladoc Health's (NYSE: TDOC) share price is proof of that. There were a handful of companies back in 2020 that had incredible bull runs as the pandemic confined many to their homes. Teladoc was one of them. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Teladoc, which offers a specialized place for doctors and patients to hold remote appointments, was founded back in 2002 and had its initial public offering (IPO) in 2015. And it had pretty steady share price growth from 2015 to 2020. Then, during the pandemic, Teladoc, Zoom, and other video-call programs saw explosive growth. When China first reported COVID-19 cases breaking out across the country in late 2019, Teladoc was trading for about $81 per share. Over the course of the next year the stock surged 224% and hit $263 per share in late January 2021. But then came the vaccine, and a slackening of pandemic-era restrictions, and by the end of 2023 life had mostly returned to normal. Unfortunately for Teladoc, so had its share price. The company finished 2023 at $21 per share, lower than it was pre-pandemic and a 92% decrease from its peak. Today it only trades for about $5, and even at these prices I wouldn't give Teladoc a look. It's fundamentally weak and lacks a real moat to protect itself. Somebody call a doctor Teladoc has one glaring problem shared by most of the video calling companies like it. There's a lot ...